Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia

被引：3

作者：

Milionis, HJ

Bairaktari, ET

Liberopoulos, EN

Elisaf, MS

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 02期

关键词：

D O I：

10.1016/S0002-9149(01)01660-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：203 / 203

页数：1

共 50 条

[41] Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?
Michael H Davidson
Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 594 - 595
[42] Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?
Davidson, Michael H.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (11): : 594 - 595
[43] Effects of Simvastatin alone versus Fenofibrate alone versus Simvastatin plus Fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia
Athyros, Vasilios G.
Kakafika, Anna I.
Koragiannis, Asterios
Mikhalidis, Dirnitri P.
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (11): : 1679 - 1680
[44] Comparative metabolic effects of fenofibrate and atorvastatin in patients with combined hyperlipiderma
Koh, KK
Han, SH
Quon, MJ
Kang, WC
Shin, MS
Choi, S
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 396A - 396A
[45] Effects of micronized fenofibrate on apo A defined HDL subfractions in patients with combined hyperlipidemia
Branchi, A
Rovellini, A
Fiorenza, AM
Sommariva, D
ATHEROSCLEROSIS, 1998, 138 : S8 - S8
[46] The release of cytokines by cultured macrophages from hyperlipidemic patients treated with micronized fenofibrate
Okopien, B
Kalina, Z
Madej, A
Kowalski, J
Szygula, B
Zielinski, M
Herman, ZS
ATHEROSCLEROSIS, 1997, 134 (1-2) : 281 - 282
[47] Modeled effects of extended-release niacin versus micronized fenofibrate in a metabolic syndrome population
Stanek, Eric J.
Quimbo, Ralph
Cziraky, Mark J.
Charland, Scott L.
DIABETES, 2006, 55 : A519 - A519
[48] Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
Koh, KK
Quon, MJ
Han, SH
Chung, WJ
Ahn, JY
Seo, YH
Choi, IS
Shin, EK
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) : 1649 - 1653
[49] Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients
Lemieux, I
Salomon, H
Després, JP
ANNALS OF MEDICINE, 2003, 35 (06) : 442 - 448
[50] The anti-inflammatory and antioxidants effects ot micronized fenofibrate in patients with metabolic syndrome
Balcerak, M.
Broncel, M.
Koter-Michalak, M.
Duchnowicz, P.
Chojnowska-Jezierska, J.
ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 191 - 191

← 1 2 3 4 5 →